X4 Pharmaceuticals’ Xolremdi Receives the US FDA’s Approval for the Treatment of WHIM Syndrome
Shots: The US FDA has approved Xolremdi (mavorixafor) capsules for treating WHIM s...
Johnson & Johnson’s Sirturo Gains the CHMP’s Positive Opinion to Treat Multidrug-Resistant Tuberculosis
Shots: The CHMP has granted positive opinion to the company’s Sirturo (bedaq...
AstraZeneca’s Truqap Plus Faslodex Receives the CHMP’s Positive Opinion for Treating Breast Cancer
Shots: The CHMP's positive opinion was based on the P-III (
Takeda’s Fruquintinib Gains the CHMP’s Positive Opinion for Previously Treated Metastatic Colorectal Cancer
Shots: The CHMP has granted positive opinion to the company’s fruquintinib (...
The US FDA Approves the Label Update of Gilead’s Biktarvy for Pregnant Adults with HIV
Shots: The US FDA approved label update with additional safety & efficacy data...
Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) Receives US FDA Approval for Adults with Hemophilia B
Shots: US FDA granted approval to Pfizer’s BEQVEZ, based on
